AIM ImmunoTech Inc
AIM
AMX
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
0.57
USD
0.00
(-0.05%)
Optionable: No Market Cap: 24 M 90-day average vol: 127,926
Previous close: 0.57 Open: 0.57 Bid: 0.58 Ask: 0.58
52 week range
0.55 2.05
Last updated: Monday 26th September 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Financials
AIM Income Statement
Annual
| Dec-12 | Dec-13 | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 213000 | 150000 | 197000 | 133000 | 92000 | 437000 | 367000 | 140000 | 163000 | 135000 |
| Cost of sales | 1 M | 367000 | 109000 | 408000 | -195000 | 172000 | 6000 | 101000 | 73000 | 75000 |
| Gross operating profit | -2 M | -1 M | -1 M | -1 M | -1 M | -746000 | -517000 | -753000 | -643000 | -715000 |
| Selling Gen & administrative expense | 9 M | 8 M | 9 M | 7 M | 8 M | 7 M | 6 M | 7 M | 9 M | 9 M |
| Research & development expense | 10 M | 8 M | 9 M | 8 M | 5 M | 4 M | 5 M | 5 M | 6 M | 8 M |
| Operating income | -20 M | -17 M | -19 M | -17 M | -14 M | -11 M | -11 M | -12 M | -15 M | -17 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | 1 M | 167000 | 995000 | 1 M | 6 M | 3 M | 2 M | 3 M | 1 M | -2 M |
| Pre-tax Income (EBT) | -17 M | -16 M | -17 M | -15 M | -8 M | -8 M | -10 M | -9 M | -14 M | -19 M |
| Income taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from total operations | -17 M | -16 M | -17 M | -15 M | -8 M | -8 M | -10 M | -9 M | -14 M | -19 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | -17 M | -16 M | -17 M | -15 M | -8 M | -8 M | -10 M | -9 M | -14 M | -19 M |
| Preferred dividends | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net income available for common | -17 M | -16 M | -17 M | -15 M | -8 M | -8 M | -10 M | -9 M | -14 M | -19 M |
| Depreciation | 683000 | 867000 | 1 M | 1 M | 1 M | 1 M | 878000 | 792000 | 733000 | 775000 |
| Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income before depreciation (EBITDA) | -17 M | -15 M | -16 M | -14 M | -6 M | -7 M | -8 M | -8 M | -13 M | -18 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | -63.36 | -52.8 | -47.52 | -31.68 | -14.96 | -12.76 | -9.77 | -2.62 | -0.45 | -0.4 |
| Diluted EPS total | -63.36 | -52.8 | -47.52 | -31.68 | -14.96 | -12.76 | -9.77 | -2.62 | -0.45 | -0.4 |
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONSGet started today